Background: Neurofibrillary tangles formed from tau misfolding have long been considered one of the pathological hallmarks of Alzheimer's disease (AD). The misfolding of tau in AD correlates with the clinical progression of AD and inhibition or reversal of tau misfolding may protect the affected neurons. Methods: We generated 293 and SH-SY5Y cells expressing DsRed-tagged pro-aggregation mutant of repeat domain of tau (DK280 tau RD ) to test indole/indolylquinoline derivatives for reducing tau misfolding and neuroprotection. Results: Four of the 10 derivatives tested displayed good misfolding-inhibitory effects on Tet-On 293 cells. Among them, NC009-1 and NC009-7 enhanced heat-shock 27 kDa protein 1 (HSPB1) expression to increase ΔK280 tau RD -DsRed solubility and promoted neurite outgrowth in Tet-On SH-SY5Y cells. Knockdown of HSPB1 resulted in decreased ΔK280 tau RD -DsRed solubility and reduced neurite outgrowth, which were rescued by addition of NC009-1/NC009-7. Treatment with indole/indolylquinoline derivatives also improved neuronal cell viability and neurite outgrowth in mouse hippocampal primary culture under tau cytotoxicity. Conclusion: Our results demonstrate how indole/indolylquinoline derivatives are likely to work in tau misfolding reduction, providing insight into the possible working mechanism of indole and indolylquinoline derivatives in AD treatment.
Introduction
Compelling evidence from basic molecular biology has demonstrated the roles of tau misfolding in the pathogenesis of Alzheimer's disease (AD) and other neurodegenerative tauopathies including frontotemporal dementia, progressive supranuclear palsy, corticobasal degeneration, and others [1] . Pathological inclusions containing the microtubule-associated protein tau in its misfolded form are a characteristic hallmark of these neurodegenerative diseases [2] . These misfolded tau proteins may assemble and accumulate at the early stage of neurodegeneration [3] .
When aggregates grow and enlarge, they may confer death signals and play a critical role in the pathogenesis of the diseases [4] . Some mechanisms, such as chaperones and the ubiquitin-proteasome system, likely remove misfolded proteins and rescue the neurons, particularly in the early stage of tauopathies [5] . Thus, identification of potential tau misfolding inhibitors targeting these pathways could be a strategy for disease progression modification in these neurodegenerative diseases.
Encoded on chromosome 17, tau is expressed abundantly in neuronal axons [6] , where they play an important role in microtubule dynamics and assembly [7, 8] , and in axonal transport [9] .
Tau can undergo a misfolding change toward b-sheet structure to aggregate into insoluble polymers [10] . Tau is subdivided into four regions: an N-terminal projection region, a proline-rich domain, a microtubule-binding domain, and a C-terminal region [11] . Among these, the microtubule-binding domain contains three or four highly conserved 18-amino acid repeat domains (tau RD ) [12] . A pro-aggregation deletion mutant ΔK280 within tau RD (ΔK280 tau RD ) was found in patients with AD and other tauopathies [13, 14] . Overexpression of ΔK280 tau RD in mouse neuroblastoma cell lines N2a is highly prone to being misfolded and forming aggregation [15] [16] [17] . Anthraquinones and N-phenylamines can prevent misfolding of ΔK280 tau RD and are thought to be candidates for treating AD and tauopathies [15, 16, 18] . Thus, the cell model based on this pro-aggregation mutation can be used in screening for candidate compounds to be used in treating tauopathies.
Small aromatic molecules have demonstrated their potential to inhibit protein misfolding by modulating the aromatic cores within amyloidogenic peptides [16, [19] [20] [21] . Here, we developed cell models based on human embryonic kidney (HEK)-293 and human neuroblastoma SH-SY5Y cells that allow the Tet-On inducible expression of pro-aggregation ΔK280 tau RD mutation, to test the potential of 10 aromatic indole/indolylquinoline derivatives [22, 23] to moderate tau misfolding. Two of them demonstrated an ability to reduce misfolding and increase solubility of ΔK280 tau RD -DsRed and to promote neurite outgrowth by upregulating small molecular chaperone heat-shock 27 kDa protein 1 (HSPB1) in the above cell models. We further validated their neuroprotective effects against tau cytotoxicity using a mouse hippocampal primary culture model. These findings suggest the potential of aromatic indole/indolylquinoline derivatives as novel tau misfolding inhibitors and neuroprotective compounds for neurodegeneration treatment.
Methods pcDNA5/FRT/TO/tau RD -DsRed Constructs
Full-length tau cDNA [24] was obtained from Dr. Pei-Jung Lu, Kaohsiung Veterans General Hospital, Taiwan. The 387-bp cDNA fragment containing wild-type (WT) tau RD region (+1497 to +1883, XM_005275646) was amplified using primers 5 0 -GCGGCCGCCCCCTTCACCATGCAGACAGCCCCCGTGCCC (NotI site and added ATG codon underlined) and 5 0 -GGATCCTT-CAATCTTTTTATTTCCTCC (BamHI site underlined). The amplified tau RD -containing fragment was cloned into pGEM-T Easy (Promega, Fitchburg, WI, USA) and sequenced. To clone DsRed, the BglII-BamHI fragment containing MCS was first removed from pDsRed-Monomer-C1 (Clontech, Palo Alto, CA, USA). Then, the EcoRI site was added and the ATG codon was removed using primers 5 0 -GAATTCGACAACACCGAGGACGTC (EcoRI site under- 
Tau RD -DsRed 293 Cell Lines
Human 293-derived Flp-In TM -293 cells (Invitrogen) were cultured as described before [25] . Cloned pcDNA5/FRT/TO/tau RD -DsRed (WT and pro-aggregation ΔK280 mutant) plasmids were used to generate isogenic cell lines by targeting insertion into Flp-In TM -293 cells, following the supplier's instructions. These cell lines were grown in medium containing 5 lg/mL blasticidin and 100 lg/mL hygromycin (InvivoGen, San Diego, CA, USA).
Tau RD -DsRed Thioflavin S Staining and Fluorescence Intensity Assays
Tau RD -DsRed 293 cells were plated into 96-well (2 9 10 4 /well) dishes, grown for 24 h, and pretreated with congo red or indole/ indolylquinoline derivatives (1-10 lM) for 8 h. Then, doxycycline (1 lg/mL, BD, Franklin Lakes, NJ, USA) was added to the medium to induce tau RD -DsRed expression for 3 days. Cells were stained with thioflavin S as described and fluorescence was quantified using a flow cytometer (BD) to measure the inhibitory effects of the tested compounds on tau misfolding. In addition, cells were stained with Hoechst 33342 (0.1 lg/mL, SigmaAldrich) and fluorescence intensities (543 nm excitation and 593 nm emission for DsRed; 377 nm excitation and 447 nm emission for Hoechst 33342) were measured using a high-content analysis (HCA) system (ImageXpressMICRO; Molecular Devices, Sunnyvale, CA, USA).
Reactive Oxygen Species (ROS) Analysis
Tau RD -DsRed 293 cells were seeded in 12-well (1.6 9 10 5 /well) plates and grown for 24 h. After 8-h treatment with congo red or indole/indolylquinoline compound NC009-1/NC009-2/NC009-6/ NC009-7 (10 lM), ΔK280 tau RD -DsRed expression was induced for 3 days as described. /well) plate. On day 2, cells were treated with congo red or the tested compound (10 lM) for 8 h, and then tau RD -DsRed expression was induced with doxycycline (1 lg/mL). The cells were kept in a medium containing trans retinoic acid, doxycycline, and compounds for 1 week. Cells were fixed in 4% paraformaldehyde, permeabilized with 0.1% Triton X-100, blocked in 3% BSA, and stained with primary anti-TUBB3 (neuronal class III b-tubulin) antibody (1:1000, Covance, Princeton, NJ, USA) at 4°C overnight and secondary anti-rabbit Alexa Fluor â555 antibody (1:500, Molecular Probes, Waltham, MA, USA) at room temperature for 3 h. Nuclei were detected using 4 0 -6-diamidino-2-phenylindole (DAPI, Sigma-Aldrich). The total neurite outgrowth was examined and quantified using a neurite outgrowth application module in MetaXpress Image Acquisition and Analysis software from Molecular Devices LLC.
Western Blot Analysis
Proteins (25 lg) in lysis buffer containing 50 mM Tris-HCl, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 0.1% SDS, 0.5% sodium deoxycholate, 1% Triton X-100, and protease inhibitor cocktail (Calbiochem, San Diego, CA, USA) were separated using 10% SDS-polyacrylamide gel electrophoresis and blotted on to nitrocellulose membranes by reverse electrophoresis. The blocked membrane was probed with anti-DsRed (1:500, Santa Cruz, Dallas, TX, USA), anti-HSPB1 (1:500, Santa Cruz), anti-a-tubulin (1:5000, GeneTex, Irvine, CA, USA), anti-pS262 tau (1:1000, Millipore, Billerica, MA, USA), anti-pS396 tau (1:1000, Invitrogen),
anti-pT231 tau (1:1000, Invitrogen), anti-total tau (HT7, 1:500, Thermo Scientific, Sunnyvale, CA, USA), and anti-b-actin (1:5000, Millipore) at 4°C overnight. Immunocomplex was detected by horseradish peroxidase-conjugated goat anti-mouse, goat anti-rabbit, or donkey anti-goat IgG antibody (1:5000, GeneTex), and protein bands were revealed by chemiluminescent substrate (Millipore).
RNA Interference
Lentiviruses with short hairpin RNA (shRNA) targeting HSPB1 (TRCN0000008753, target sequence CCGATGAGACTGCCGC-CAAGT) and a negative control scrambled shRNA (TRC2.Void) were obtained from National RNAi Core Facility, Institute of Molecular Biology/Genomic Research Center, Academia Sinica, Taipei, Taiwan. Lentiviruses were prepared according to the standard protocol. SH-SY5Y ΔK280 tau RD -DsRed cells were plated at a density of 2 9 10 4 /well (24-well plates for neurite outgrowth analysis) or 6 9 10 5 /well (six-well plates for protein analysis) with retinoic acid (10 lM) added on day 1 and transduced with lentivirus (multiplicity of infection, 3) in medium containing 8 lg/mL polybrene (Sigma-Aldrich) on day 2. At 24 h postinfection, the culture medium was changed and cells were pretreated with NC009-1/NC009-7 (10 lM) for 8 h followed by induction of ΔK280 tau RD -DsRed expression (doxycycline, 1 lg/mL) for 1 week. Then, the cells were analyzed for neurite outgrowth as described or were collected for HSPB1 and ΔK280 tau RD -DsRed proteins analysis.
Animals and Primary Hippocampal Neuronal Culture
The mouse hippocampal primary culture was performed as in our previous report [27] . The hippocampus of embryonic day 16-18 C57BL/6J mouse was trypsinized (0.05%) for 15 min at 37°C. Isolated cells (3 9 10 4 cells/cm 2 ) were cultured in neurobasal media (Gibco) containing a 2% B27 supplement (Gibco), 0.5 mM glutamine, 25 lM glutamate, penicillin/streptomycin (20 unit/mL), 1 mM HEPES, and 1% heat-inactivated donor horse serum (Gibco) on poly-L-lysine (100 lg/mL)-coated plates. Cytosine arabinoside (2 lM, Sigma-Aldrich) was added on day 4 to reduce the glial cell population. All animal experimental procedures were performed according to the guidelines established by the Institutional Animal Care and Use Committee of National Taiwan Normal University, Taipei, Taiwan.
Compound Treatment and Immunocytochemical Staining of Hippocampal Primary Culture
Tau hyperphosphorylation was induced in the mouse hippocampal primary culture by wortmannin (WM) and GF109203X (GFX), as described previously [28, 29] . At in vitro culture day 9 (DIV9), indole/indolylquinoline derivatives (1-30 lM) were administrated to the primary culture 30 min before the WM (10 lM) and GFX (10 lM) treatment. One hour later, cells were fixed with ice-cold 4% paraformaldehyde (Sigma-Aldrich) and the nonspecific epitopes were blocked by 10% fetal bovine serum. NeuN and MAP2 (Millipore)], DAPI, and fluorescence-tagged secondary antibody. The mature neuron (identified by NeuN + staining) cell number and neurite length (identified by MAP2 staining) were analyzed using MetaXpress Image Acquisition and Analysis software (Molecular Devices), as described previously [27] . For Western blot analysis and thioflavin S staining, cells were harvested for protein extraction and staining after treatment with indole/indolylquinoline derivatives (10 lM) for 12 h.
Statistical Analysis
Three independent experiments were performed. For each set of values, data were expressed as the means AE standard deviation (SD). The differences among groups were evaluated by Student's t-test or one-way ANOVA with a post hoc LSD test where appropriate. All P values were two-tailed, and P < 0.05 was considered significant.
Results

Indole/Indolylquinoline Derivatives and Solubility
Indole/indolylquinoline derivatives contain aromatic heterocyclic nuclei of indole (chemical formula C 8 H 7 N) and/or quinoline (chemical formula C 9 H 7 N), and are present in a wide variety of biologically active compounds, such as anticancer drugs [30] , selective phosphodiesterase four inhibitors [31] , antiparasite agents [32] , and tau aggregation inhibitors [33] . As effective treatments that modify the progression of AD are still not available, we explored the potential of 10 indole/indolylquinoline derivatives ( Figure 1 ) for use in tau misfolding reduction. Among them, NC009-1, NC009-2, NC009-4, NC009-5, NC009-6, and NC009-11
were C-alkylated indole derivatives and NC009-7, NC009-8, NC009-9, and NC009-10 were indolylquinoline compounds generated from reductive cyclization of indole derivatives. The solubility of these compounds in culture medium was examined first. After vortex mixing and centrifugation (15,000 g for 5 min), all the tested compounds were completely soluble in medium up to 10 lM.
Cloning and Expression of tau RD -DsRed Constructs
Tau protein is the major component of the neurofibrillary tangles (NFT) that constitute the defining neuropathological characteristic of AD and other tauopathies. Tau-based drug discovery studies that look for small molecule inhibitors targeting tau misfolding provide an alternative route to existing pharmaceutical strategies.
To establish a cell model targeting tau misfolding, WT and proaggregation mutant (ΔK280) tau RD -DsRed were cloned. To examine the misfolding of tau RD , the tau RD -DsRed constructs were transiently expressed in HEK-293 cells and probed by thioflavin S for fluorescence microscopy examination. Due to its binding to bsheet-rich amyloid structures and providing a distinct increase in fluorescence emission, thioflavin S fluorescence is a faithful marker of the misfolding of tau [34] . As predicted, quantification of relative fluorescent intensity revealed significantly increased thioflavin S fluorescence in ΔK280 tau RD -DsRed-expressing cells compared to WT tau RD -DsRed-expressing cells (Figure 2A , 23% vs. 36%, P = 0.012).
Tet-On tau RD -DsRed 293 Cells
HEK-293 cells express many neuron-specific mRNAs [35] and have been used to study tau misfolding, phosphorylation, and mutations [36] [37] [38] . Therefore, we used a HEK-293-derived cell line to generate Tet-On tau RD -DsRed (WT and ΔK280) cell clones. DsRed antibody detected 43 kDa tau RD -DsRed fusion proteins in immunoblot ( Figure 2B ). Real-time PCR quantification of these tau RD lines showed similar WT/ΔK280 tau RD -DsRed RNA expression levels after induction with doxycycline (+ Dox) for 2 days ( Figure 2C) . A protein-folding reporter, in which a fluorescent protein is fused to the C-terminus of a protein of interest [39] , is widely used to monitor the folding of proteins in cells. With this, misfolded proteins disturb the formation of the chromophore responsible for protein fluorescent properties and lead to decreased cellular fluorescence intensity. DsRed fluorescence was used to reflect tau misfolding status in tau RD -DsRed-expressing cells, as tau aggregated rapidly to cause the misfolding of fused DsRed. Inhibition of tau misfolding may also improve DsRed misfolding, leading to increasing fluorescence on tau RD -DsRed-expressing cells. Cells were pretreated with congo red (10 lM) for 8 h before inducing tau RD -DsRed expression for 3 days ( Figure 2D ). Fluorescent images of Tet-On WT/ΔK280 tau RD -DsRed cells are shown in Figure 2E . Quantification of relative fluorescent intensity revealed significantly decreased ΔK280 tau RD -DsRed fluorescence compared to WT tau RD -DsRed fluorescence (73% vs. 100%, P < 0.001). Congo red, a known tau misfolding inhibitor [40] , significantly increased red fluorescent intensity (from 73% to 81% at 10 lM concentration, P = 0.003) in ΔK280 tau RD -DsRed cells, whereas the increase in red fluorescence (2%) on congo red-treated WT tau RD -DsRed cells was not significant.
Tau misfolding has been reported to be associated with the generation of reactive oxygen species (ROS) [41] . To evaluate whether the pro-aggregated tau RD -DsRed increased ROS formation, the cellular production of ROS was measured. Although induced expression of WT tau RD -DsRed did not increase the ROS level compared to uninduced cells (97% vs. 100%, P = 0.400), treatment with congo red (10 lM) significantly reduced the ROS level (87%, P = 0.034) compared to no treatment (97%) (Figure 2F) . However, the induced expression of pro-aggregated ΔK280 tau RD -DsRed significantly increased the ROS level compared to uninduced cells (112% vs. 100%, P = 0.013), and treatment with congo red (10 lM) also significantly reduced the ROS level (92%, P = 0.002) compared to no treatment (112%).
Tests of Indole/Indolylquinoline Derivatives in Reducing tau RD Misfolding and ROS
As thioflavin S fluorescence reflected the misfolding of pro-aggregated tau faithfully, Tet-On ΔK280 tau RD -DsRed 293 cells were first treated with the tested compounds (10 lM) and intracellular tau aggregate formation was measured with fluorescence generated by thioflavin S binding. Congo red significantly decreased thioflavin S fluorescence (from 100% to 90%, P = 0.020) in ΔK280 tau RD -DsRed cells ( Figure 3A) . Treatment with four of the 10 tested indole/indolylquinoline compounds revealed significantly reduced thioflavin S fluorescence, compared to no treatment (100%); these were NC009-1 (88%, P = 0.027), NC009-2 (92%, P = 0.033), NC009-6 (91%, P = 0.022), and NC009-7 (93%, P = 0.014) ( Figure 3A) . These four compounds also displayed potential to reduce Ab aggregation, using a biochemical assay to measure Ab aggregate formation with fluorescence generated by thioflavin T binding [42] .
We then used Tet-On ΔK280 tau RD -DsRed 293 cells to examine NC009-1, NC009-2, NC009-6, and NC009-7 (1-10 lM) for their ability to inhibit tau RD misfolding. Congo red (10 lM) significantly increased ΔK280 tau RD -DsRed fluorescence to 110% (P = 0.003), compared to no treatment (100%) ( Figure 3B ). Significantly increased DsRed fluorescence was observed with all four compounds at 10 lM (107-113%, P = 0.022-0.005), compared to no treatment (100%). According to the survived cell number analyzed, IC 50 cytotoxicity of congo red, NC009-1, NC009-2, NC009-6, and NC009-7 was 43 lM, 14 lM, 16 lM, 36 lM, and 32 lM, respectively, in 293 cells expressing ΔK280 tau RD -DsRed for 3 days.
To evaluate whether the tested compounds reduced ROS formation in the 293 ΔK280 tau RD -DsRed cells, the cellular production of ROS was measured. Induced expression of ΔK280 tau RD -DsRed significantly increased the ROS level compared to uninduced cells (112% vs. 100%, P = 0.020) ( Figure 3C ). Treatment with congo red (10 lM) significantly reduced the ROS level compared to no treatment (91% vs. 112%, P = 0.002). In addition, NC009-1, NC009-6, and NC009-7 (10 lM) significantly ameliorated oxidative stress induction by ΔK280 tau RD -DsRed (93-77% vs. 112%, P = 0.033-0.011). When tau RD -DsRed RNA levels were examined with real-time PCR, the addition of congo red or NC009-1 did not significantly change the tau RD -DsRed RNA level ( Figure 3D ).
Indole/Indolylquinoline Derivatives Promoted Neurite Outgrowth on Tet-On tau RD -DsRed SH-SY5Y Cells
Excessive ROS induces reconfiguration of microtubules and reduces neurite outgrowth [43] . The reduction of ROS by the identified indole/indolylquinoline compounds may provide neuroprotection by improving neurite outgrowth in neuronal cell models. The SH-SY5Y in vitro model is useful in many areas of neuroscientific research, including the AD field [44] . Therefore, we constructed Flp-In SH-SY5Y cells with ΔK280 tau RD -DsRed expression in an inducible fashion. Similar to the Tet-On 293 cells, 43 kDa ΔK280 tau RD -DsRed fusion proteins ( Figure 4A ) and 9-fold of RNA expression ( Figure 4B ) were observed after induction with doxycycline (+ Dox) for 2 days.
We then used ΔK280 tau RD -DsRed SH-SY5Y cells to examine the neuroprotective potentials of the above indole/indolylquinoline derivatives. The ΔK280 tau RD -DsRed SH-SY5Y cells were differentiated with retinoic acid (10 lM) [45] . Neurite outgrowth was analyzed on differentiated SH-SY5Y cells after 8 h pretreatment with 10 lM tested compounds, followed by doxycycline-induced ΔK280 tau RD -DsRed expression ( Figure 4C ). Representative fluorescence microscopy images of untreated and congo red/NC009-7-treated cells are shown in Figure 4D . Induced expression of ΔK280 tau RD -DsRed significantly reduced neurite outgrowth compared to the absence of induction (89% vs. 100%, P = 0.005) ( Figure 4E ). Examination of neurite features of ΔK280 tau RD -DsRed SH-SY5Y cells revealed that treatment with congo red significantly improved neurite outgrowth compared to no treatment (98% vs. 89%, P = 0.021). Two of the four tested indole/indolylquinoline derivatives, NC009-1 and NC009-7, also significantly improved neurite outgrowth on ΔK280 tau RDDsRed-expressing SH-SY5Y cells (103-105% vs. 89%, P < 0.001).
Indole/Indolylquinoline Compounds Enhanced HSPB1 Expression to Assist ΔK280 Tau RD 
-DsRed Folding
The indolyl compound indomethacin was shown previously to induce HSP expression and suppress protein misfolding and apoptosis [46] . Heat-shock proteins had been speculated to function as regulators of soluble tau protein levels [47] . Small heat-shock protein HSPB1 can prevent pathological misfolding of tau by altering the conformation of hyperphosphorylated tau and rescue hyperphosphorylated tau-mediated cell death [48] . Thus, we examined whether the tested indole/indolylquinoline compounds upregulated HSPB1 expression in SH-SY5Y cells, to assist ΔK280 tau RD -DsRed folding. Addition of NC009-1/NC009-7 significantly increased HSPB1 (124-130% vs. 100%, P = 0.034-0.013) and soluble ΔK280 tau RD -DsRed (157-257% vs. 100%, P < 0.001) protein levels ( Figure 5A ), but no significant change was observed in the relative ΔK280 tau RD -DsRed/HPRT1 RNA level between untreated and NC009 compound-treated cells (data not shown).
We then explored the inhibiting role of HSPB1 gene silence in ΔK280 tau RD -DsRed solubility and neurite outgrowth by lentivirus-mediated RNA interference. Differentiated ΔK280 tau RDDsRed SH-SY5Y neuronal cells were infected with HSPB1-specific shRNA or a negative control construct (scramble shRNA). The next day, cells were pretreated with NC009-1/NC009-7 for 8 h followed by doxycycline-induced ΔK280 tau RD -DsRed expression for 7 days. Treatment with NC009-1/NC009-7 significantly increased HSPB1 protein expression ( Figure 5B , 120-134% vs. 106%, P = 0.004-0.036), increased soluble ΔK280 tau RD -DsRed protein levels ( Figure 5B , 232-642% vs. 100%, P = 0.028-0.003), and improved neurite outgrowth ( Figure 5C , 102-109% vs. 91%, P = 0.025-0.024), compared to the untreated cells. However, NC009-1/NC009-7-treated ΔK280 tau RD -DsRed SH-SY5Y cells infected with HSPB1-specific shRNA revealed downregulated HSPB1 protein expression ( Figure 5B , 79-87% vs. 120-134%, P = 0.003-0.028), decreased soluble ΔK280 tau RD -DsRed protein levels ( Figure 5B , 66-133% vs. 232-642%, P = 0.005-<0.001), and reduced neurite outgrowth ( Figure 5C , 85-94% vs. 102-109%, P = 0.011-0.029), compared to the scramble control.
Molecular chaperones form the first line of defense to prevent protein misfolding and aggregation. Among these chaperones, HSPB1 has recently emerged as a particularly potent neuroprotectant against polyglutamine, a-synuclein, and Ab-induced toxicity [49] [50] [51] . Overexpression of HSPB1 ameliorated symptoms of AD in APP/PS1 mice [52] . Our study results of synthetic indolylquinoline derivatives enhancing HSPB1 expression to promote neurite outgrowth in ΔK280 tau RD -DsRed-expressing SH-SY5Y cells also support the notion that enhancing HSPB1 expression may be a potent therapeutic pathway for neuroprotection in AD.
Neuroprotective Effect of Indole/ Indolylquinoline Derivatives on Mouse Hippocampal Primary Culture Under Tau Cytotoxicity
Coadministration of WM (a specific PI3K inhibitor) and GF-109203X (GFX, a specific PKC inhibitor) for GSK-3b activation induced prolonged Alzheimer-like tau hyperphosphorylation in mouse neuroblastoma N2a cells [53] . WM/GFX induced tau hyperphosphorylation and damaged the microtubular cytoskeleton of the SH-SY5Y cells [29] . It was demonstrated that activation of GSK-3 by WM/GFX caused a memory deficit through hyperphosphorylation of tau and suppression of acetylcholine in the rat hippocampus [54] . We have also observed that tau phosphorylation at Thr205, Thr231, and Ser396 was upregulated by WM and GFX treatments in mouse hippocampal primary culture (data not shown), which suggests that WM/GFX-treated cells could imitate an AD platform with tau protein hyperphosphorylation. Therefore, this system was used to validate the neuroprotective activity of the indole/indolylquinoline compounds. WM/GFX treatment significantly reduced total cells ( Figure 6A , 71%, P < 0.001), mature neuron cells ( Figure 6B , 72%, P < 0.001), and total neurite length ( Figure 6C , 75%, P < 0.001), compared to vehicle treatment. The indole/ Figure 6 Confirming the neuroprotective effects of indole/indolylquinoline compounds by mouse hippocampal primary culture under tau toxicity. WM/GFX (10 lM) was applied to the primary culture 30 min after the NC009 compound administration (1, 10, or 30 lM) at DIV9. Cells were fixed 1 h later for immunocytochemical analysis and quantification of the total cell number (A, by DAPI staining), mature neuron numbers (B, by NeuN antibody staining), and neurite length (C, by MAP2 antibody staining). To normalize, the relative amount of cells treated with vesicle (DMSO) was set as 100% (n = 3).
indolylquinoline compounds NC009-1, NC009-2, NC009-6, and NC009-7 (1, 10 or 30 lM) significantly improved the number of total cells ( Figure 6A , 87-129% vs. 71%, P = 0.026-<0.001), mature neuron cells ( Figure 6B , 101-134% vs. 72%, P = 0.009-<0.001), and neurite outgrowth ( Figure 6C , 88-147% vs. 75%, P = 0.003-<0.001) against the tau cytotoxicity induced by WM/ GFX in the hippocampal primary culture.
We then examined the levels of p-tau protein at different sites after treatment. WM/GFX increased tau protein phosphorylation at Ser262 ( Figure 7A , 161%, P = 0.029) and Thr231 (Figure 7B, 237% , P = 0.041), compared to the vehicle treatment (100%), while treatment with the indole/indolylquinoline compounds NC009-7 and NC009-1 significantly reduced the p-tau at Ser262 ( Figure 7A , 52%, P < 0.001) and Thr231 (Figure 7B , 67%, P = 0.011), respectively. NC009-1, NC009-6, and NC009-7 also reduced the p-tau at Ser396, although not significantly ( Figure 7B ). In addition, quantification of relative fluorescent intensity revealed that treatment with NC009-1, NC009-2, NC009-6, and NC009-7 (10 lM) significantly reduced thioflavin S-stained aggregates in hippocampal primary culture, compared to the WM/GFX group ( Figure 7C , 59-76% vs. 191%, P < 0.001). These data indicate that the neuroprotective effects of indole/indolylquinoline compounds in the primary culture could be attributed to the reduction of tau phosphorylation and aggregation.
In the current study, the tested indole/indolylquinoline compounds presented a capability to reduce tau misfolding (NC009-1, 2, 6, 7) and generation of ROS (NC009-1, 6, 7) in Tet-On 293 cells. NC009-1 and NC009-7 promoted neurite outgrowth and HSPB1 upregulation on neuronal differentiated Tet-On SH-SY5Y cells. Different substituents on the indole part affected the activity of these compounds. Compounds with the electron-releasing group but without strong nucleophiles (NC009-2 and NC009-6) were better than compounds with the electron-withdrawing group (NC009-4, NC009-5, and NC009-11), while indole without modification (NC009-1) was the best. The reductive cyclization of NC009-1 enhances the power of NC009-1, as the resultant indolylquinoline derivative NC009-7 displayed the best neuroprotective activity in neuronal SH-SY5Y cells and mouse hippocampal primary culture. Figure 7 Effects of indole/indolylquinoline compounds on reducing tau phosphorylation and aggregation in mouse hippocampal primary culture. WM/GFX (10 lM) was applied to the primary culture before the NC009 compound administration (10 lM) at DIV9. Cells were harvested 12 h later for Western blot analysis of tau phosphorylation at Ser262 (A), Ser396, and Thr231 (B). In addition, thioflavin S staining of aggregates in primary culture assay was performed (C). To normalize, the relative amount of proteins and thioflavin S-stained signals of cells treated with vesicle (DMSO) was set as 100% (n = 3). *compared to group without WM/GFX treatment; # compared to group with WM/GFX treatment. * ,# P < 0.05; **P < 0.01; *** ,### P < 0.001.
Conclusion
Tau protein is the major component of the NFT that constitute the defining neuropathological characteristics of AD and other tauopathies. Tau-based drug discovery studies that look for small molecule inhibitors of tau misfolding provide an alternative to existing pharmaceutical strategies. Phase 3 trials for methylthioninium chloride, one of the identified tau misfolding inhibitors [55] , are currently underway [56] . In this study, we used human 293/SH-SY5Y cells with inducible ΔK280 tau RD -DsRed expression and mouse hippocampal primary culture under tau cytotoxicity to demonstrate that novel synthetic indole/indolylquinoline derivatives upregulated HSPB1 expression to reduce tau misfolding and promote neurite outgrowth. Our in vitro study provides strong evidence that indole/indolylquinoline derivatives could be novel therapeutics for AD. Future application of the synthetic indole/indolylquinoline derivatives to AD animal models is warranted to consolidate their effects on misfolding reduction and potential prevention of disease progression.
